Results 51 to 60 of about 9,670 (235)

Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma [PDF]

Blood Cancer J
Mengyan Zhu, Ning Li, Lei Fan, Rongrong Wu, Lei Cao, Yimin Ren, Chuanyang Lu, Lishen Zhang, Yun Cai, Yuzhu Shi, Zihan Lin, Xueying Lü, Jia‐yan Leng, Shiyang Zhong, Xianglin Hu, Bin Huang, Renhong Huang, Wanting Zhou, Diru Yao, Lingxiang Wu, Wei Wu, Quanzhong Liu, Peng Xia, Ruize Chen, Wenyu Shi, Ruohan Zhang, Sali Lv, Chunling Wang, Liang Yu, Jianyong Li, Qianghu Wang, Kening Li, Hui Jin   +32 more
openalex   +2 more sources

Erythema Multiforme Major in Angioimmunoblastic T-cell Lymphoma

Acta Dermato-Venereologica, 2021
is missing (Short communication)
Shoko Hattori, Fumi Miyagawa, Keiko Fukuda, Kohei Ogawa, Hideo Asada   +4 more
doaj   +1 more source

Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock

Hematology Reports, 2023
Diffuse large B-cell lymphoma (DLBCL) and angioimmunoblastic T-cell lymphoma (AITL) are two subtypes of non-Hodgkin lymphoma (NHL). The simultaneous occurrence of DLBCL and AITL in a composite lymphoma is very rare, and there are no established treatment
Nisha Hariharan, Alisha Kabadi, Michelle Don, Mazen Odish, Benjamin Heyman   +4 more
doaj   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study [PDF]

, 2013
PURPOSE: The differential diagnosis among the commonest peripheral T-cell lymphomas (PTCLs; ie, PTCL not otherwise specified [NOS], angioimmunoblastic T-cell lymphoma [AITL], and anaplastic large-cell lymphoma [ALCL]) is difficult, with the morphologic ...
Agostinelli, C., Bacci, F., Bellei, Monica, Bertuzzi, C., Chan, J. C., De Leo, A., Federico, Massimo, Fuligni, F., Gazzola, A., Hansmann, M. L., Hartmann, S., Inghirami, G., Iqbal, J., Laginestra, M. A., Mannu, C., Piccaluga, P. P., Pileri, S. A., Piva, R., Rossi, M., Sabattini, E., Sapienza, M. R., Vose, J. M., Weisenburger, D., Zinzani, P. L.   +23 more
core   +1 more source

Restricted Expression of the Constant Region 1 of T‐Cell Receptor β by Flow Cytometry Facilitates Detection of T‐Cell Neoplasms With High Specificity but Moderate Predictive Value

European Journal of Haematology, Volume 116, Issue 3, Page 245-255, March 2026.
ABSTRACT Objectives To determine the diagnostic value of disclosing monotypic T‐cell populations by expression analysis of the constant region 1 of T‐cell receptor β (TRBC1) by flow cytometry, for the detection of T‐cell neoplasms, in a routine hematopathology practice setting.
Nilofar Rajabian, Olof Axler, Erik Wistén, Anna Porwit, Mats Ehinger   +4 more
wiley   +1 more source

Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma

Zhongliu Fangzhi Yanjiu, 2020
Objective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based
WEN Tingyu, GUI Lin, JIN Jun, ZHANG Wei, WANG Ting, SHI Yuankai, LIU Peng   +6 more
doaj   +1 more source

Immunoglobulinopathies in patients with angioimmunoblastic T-cell lymphoma [PDF]

Терапевтический архив, 2018
Contex. Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of non-Hodgkins lymphoma, characterized by generalized lymphadenopathy, hepatosplenomegaly and dysproteinemia. Hypergammaglobulinaemia is revealed in 50-83% pts with AITL.
N G CHERNOVA, N P SOBOLEVA, S A MARIINA, Y V SIDOROVA, M N SINITSYNA, V N DVIRNYK, D S BADMAZHAPOVA, Y E VINOGRADOVA, E E ZVONKOV, V G SAVCHENKO   +9 more
doaj   +1 more source

Diffuse Large B-cell Lymphoma in Patient after Treatment of angioimmunoblastic T-cell Lymphoma [PDF]

, 2010
Relatively few cases of Epstein-Barr (EBV)-positive B-cell lymphomas arising in patients with angioimmunoblastic T-cell lymphoma (AITL) have been reported.
Branimir Jakšić, Delfa Radić-Krišto, Ika Kardum-Skelin, Nives Džeko Škugor, Radovan Vrhovac, Zinaida Perić   +5 more
core   +1 more source

Comparison of referring and final pathology for patients with T‐cell lymphoma in the National Comprehensive Cancer Network [PDF]

, 2014
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107537/1/cncr28676 ...
A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma, Coiffier, d'Amore, Federico, Harris, LaCasce, O'Connor, Piccaluga, Piekarz, Pro, Proctor, Rodriguez, Rodriguez, Rudiger, Schetelig, Sibon, Smith, Vose, Weisenburger, Weisenburger, Younes   +20 more
core   +1 more source